NYSE - Delayed Quote USD

Hims & Hers Health, Inc. (HIMS)

12.34 +0.01 (+0.08%)
At close: 4:00 PM EDT
12.30 -0.04 (-0.32%)
After hours: 6:51 PM EDT
Loading Chart for HIMS
DELL
  • Previous Close 12.33
  • Open 12.46
  • Bid 12.27 x 2200
  • Ask 12.42 x 1400
  • Day's Range 12.15 - 12.60
  • 52 Week Range 5.65 - 17.16
  • Volume 2,949,740
  • Avg. Volume 5,120,351
  • Market Cap (intraday) 2.644B
  • Beta (5Y Monthly) 0.91
  • PE Ratio (TTM) --
  • EPS (TTM) -0.11
  • Earnings Date May 6, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 15.71

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

www.forhims.com

1,046

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HIMS

Performance Overview: HIMS

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HIMS
38.65%
S&P 500
6.33%

1-Year Return

HIMS
5.65%
S&P 500
22.70%

3-Year Return

HIMS
8.06%
S&P 500
21.33%

5-Year Return

HIMS
--
S&P 500
68.64%

Compare To: HIMS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HIMS

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    2.64B

  • Enterprise Value

    2.43B

  • Trailing P/E

    --

  • Forward P/E

    204.08

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.96

  • Price/Book (mrq)

    7.68

  • Enterprise Value/Revenue

    2.79

  • Enterprise Value/EBITDA

    -121.91

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.70%

  • Return on Assets (ttm)

    -4.03%

  • Return on Equity (ttm)

    -7.18%

  • Revenue (ttm)

    872M

  • Net Income Avi to Common (ttm)

    -23.55M

  • Diluted EPS (ttm)

    -0.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    220.98M

  • Total Debt/Equity (mrq)

    2.89%

  • Levered Free Cash Flow (ttm)

    66.65M

Research Analysis: HIMS

Analyst Price Targets

11.00
15.71 Average
12.34 Current
20.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: HIMS

Fair Value

12.34 Current
 

Dividend Score

0 Low
HIMS
Sector Avg.
100 High
 

Hiring Score

0 Low
HIMS
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
HIMS
Sector Avg.
100 High
 

People Also Watch